9G2 Stock Overview
Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Singapore Institute of Advanced Medicine Holdings Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.092 |
| 52 Week High | S$0.20 |
| 52 Week Low | S$0.088 |
| Beta | 0 |
| 1 Month Change | -20.00% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -51.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9G2 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -3.2% | 0.9% | 2.9% |
| 1Y | n/a | -23.9% | -3.9% |
Return vs Industry: Insufficient data to determine how 9G2 performed against the SG Healthcare industry.
Return vs Market: Insufficient data to determine how 9G2 performed against the SG Market.
Price Volatility
| 9G2 volatility | |
|---|---|
| 9G2 Average Weekly Movement | 15.1% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in SG Market | 15.5% |
| 10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 9G2's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 9G2's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Shih Kien Djeng | www.advancedmedicine.sg |
Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It also provides clinic and imaging services; manufactures medical research and clinical diagnostic instruments and supplies; and sells pharmaceuticals, surgical products, and consumables.
Singapore Institute of Advanced Medicine Holdings Ltd. Fundamentals Summary
| 9G2 fundamental statistics | |
|---|---|
| Market cap | S$96.20m |
| Earnings (TTM) | -S$18.96m |
| Revenue (TTM) | S$16.23m |
5.9x
P/S Ratio-5.1x
P/E RatioIs 9G2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9G2 income statement (TTM) | |
|---|---|
| Revenue | S$16.23m |
| Cost of Revenue | S$6.37m |
| Gross Profit | S$9.87m |
| Other Expenses | S$28.83m |
| Earnings | -S$18.96m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.018 |
| Gross Margin | 60.78% |
| Net Profit Margin | -116.82% |
| Debt/Equity Ratio | 102.0% |
How did 9G2 perform over the long term?
See historical performance and comparison